MIR3129 (microRNA 3129)

2014-11-01  

Identity

HGNC
MIR3129
LOCATION
2q32.2
LOCUSID
100422908
ALIAS
mir-3129

Other Information

Locus ID:

NCBI: 100422908
HGNC: 38217
Ensembl: ENSG00000264725
miRBase:

Variants:

dbSNP: 100422908
ClinVar: 100422908
TCGA: ENSG00000264725
COSMIC: MIR3129

RNA/Proteins

References

Pubmed IDYearTitleCitations
329655972021LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.15
333365242021Elevated serum miR-3129-5p contributes to the progression of coronary heart disease via targeting mTOR.1
335635832021Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.8
329655972021LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.15
333365242021Elevated serum miR-3129-5p contributes to the progression of coronary heart disease via targeting mTOR.1
335635832021Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.8
299152832018Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44.11
299152832018Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44.11

Citation

Dessen P

MIR3129 (microRNA 3129)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/69153/gene-fusions-explorer/img/logo-atlas-4.svg